The ethical considerations surrounding performance enhancement versus legitimate medical treatment must be carefully considered, and healthcare providers should ensure that any use of these peptides in athletic populations is medically justified and compliant with applicable anti-doping regulations
Compared to CBT-I and approved sleep medications, DSIP has far weaker clinical evidence
In the women on high doses of semaglutide, women on no-HT had a significant improvement in HbA1c and systolic blood pressure and women on HT had a significant improvement in HbA1c, triglycerides, and total cholesterol, with a trend toward improvement in systolic blood pressure and LDL-cholesterol (Supplemental Table 3, We compared the changes from baseline to 12 months of each cardiometabolic risk marker among the two groups and no differences were observed (data not shown)
"This is why I am proud to be involved in this trial, which extends participation opportunities to groups often under-represented in research."
Key safety information in the Prescribing Information includes: Use in patients with prior pancreatitis: Tirzepatide has not been studied in patients with a history of pancreatitis
Consult siempre a tu mdico o a otro profesional de la salud calificado ante cualquier duda que tengas sobre una condicin mdica.